The store will not work correctly when cookies are disabled.
((S)-2-Methyl-5,6,7,8-tetrahydro-indolizin-7-yl)-dipropyl-amine
ID: ALA98072
PubChem CID: 44329039
Max Phase: Preclinical
Molecular Formula: C15H26N2
Molecular Weight: 234.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCN(CCC)[C@H]1CCn2cc(C)cc2C1
Standard InChI: InChI=1S/C15H26N2/c1-4-7-16(8-5-2)14-6-9-17-12-13(3)10-15(17)11-14/h10,12,14H,4-9,11H2,1-3H3/t14-/m0/s1
Standard InChI Key: SPZKFYULWLAAQF-AWEZNQCLSA-N
Molfile:
RDKit 2D
17 18 0 0 1 0 0 0 0 0999 V2000
10.5917 -2.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8792 -2.5500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0542 -3.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2167 -2.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5917 -1.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8792 -3.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8792 -0.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1667 -2.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1667 -1.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8792 -0.0750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2875 -4.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1667 0.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5917 0.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5917 1.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1667 1.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3125 1.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4542 1.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 2 0
5 1 1 0
6 4 1 0
7 5 1 0
8 2 1 0
9 7 1 0
7 10 1 6
11 6 1 0
12 10 1 0
13 10 1 0
14 13 1 0
15 12 1 0
16 14 1 0
17 15 1 0
6 3 2 0
8 9 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 234.39 | Molecular Weight (Monoisotopic): 234.2096 | AlogP: 3.23 | #Rotatable Bonds: 5 |
Polar Surface Area: 8.17 | Molecular Species: BASE | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.54 | CX LogP: 3.42 | CX LogD: 0.44 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.76 | Np Likeness Score: -0.94 |
References
1. Lehmann T, Hübner H, Gmeiner P.. (2001) Dopaminergic 7-aminotetrahydroindolizines: ex-chiral pool synthesis and preferential D3 receptor binding., 11 (21): [PMID:11597417] [10.1016/s0960-894x(01)00564-9] |
2. Boeckler F, Ohnmacht U, Lehmann T, Utz W, Hübner H, Gmeiner P.. (2005) CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists., 48 (7): [PMID:15801839] [10.1021/jm049269+] |